PART I . On February 10, 2021, (the Closing Date), Nuvation Bio Inc., a Delaware corporation (Legacy Nuvation Bio), Panacea Acquisition Corp. (Panacea), and Panacea Merger Subsidiary Corp, a Delaware corporation and a direct, wholly owned subsidiary of Panacea (Merger Sub) consummated the transactions contemplated by an Agreement and Plan of Merger among them dated October 20, 2020 (Merger Agreement). Pursuant to the terms of the Merger Agreement, a business combination of Panacea and Legacy Nuv...
Q2 FY2026 — expected 2026-08-05
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-02 | 2025-12-31 | 0001193125-26-085584 | EDGAR | 104K words |
| 2025-03-06 | 2024-12-31 | 0000950170-25-034903 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0000950170-24-023247 | EDGAR | — |
| 2023-03-15 | 2022-12-31 | 0000950170-23-008180 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0000950170-22-002332 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001193125-21-077880 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-03 | 2025-09-30 | 0001193125-25-262605 | EDGAR | 77K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-104626 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0000950170-25-065712 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122402 | EDGAR | — |
| 2024-08-05 | 2024-06-30 | 0000950170-24-090347 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0000950170-24-059622 | EDGAR | — |
| 2023-11-02 | 2023-09-30 | 0000950170-23-058253 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0000950170-23-038155 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0000950170-23-017926 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021943 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0000950170-22-014868 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0000950170-22-008530 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-02 | 0001193125-26-085474 | EDGAR | 5K words |
| 2026-01-12 | 0001193125-26-009826 | EDGAR | — |
| 2025-11-26 | 0001193125-25-298551 | EDGAR | — |
| 2025-11-17 | 0001193125-25-284845 | EDGAR | — |
| 2025-11-03 | 0001193125-25-262576 | EDGAR | — |
| 2025-08-07 | 0001193125-25-174954 | EDGAR | — |
| 2025-06-11 | 0001193125-25-139164 | EDGAR | — |
| 2025-05-23 | 0001193125-25-125763 | EDGAR | — |
| 2025-05-07 | 0001193125-25-114908 | EDGAR | — |
| 2025-03-25 | 0001193125-25-062031 | EDGAR | — |
90 total filings indexed. 62 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001811063 |
| Ticker | NUVB |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.nuvationbio.com |
| Listed | 2021-02-10 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report